{"id":"https://openalex.org/W2603309552","doi":"https://doi.org/10.1200/jco.2015.33.15_suppl.e19024","title":"Safety and efficacy of necitumumab continuation therapy: Subgroup analysis of phase 3 SQUIRE study.","display_name":"Safety and efficacy of necitumumab continuation therapy: Subgroup analysis of phase 3 SQUIRE study.","publication_year":2015,"publication_date":"2015-05-20","ids":{"openalex":"https://openalex.org/W2603309552","doi":"https://doi.org/10.1200/jco.2015.33.15_suppl.e19024","mag":"2603309552"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2015.33.15_suppl.e19024","doi":"https://doi.org/10.1200/jco.2015.33.15_suppl.e19024","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2015.33.15_suppl.e19024","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5001591653","display_name":"Tudor\u2013Eliade Ciuleanu","orcid":"https://orcid.org/0009-0006-5351-4234","observed_orcids":["https://orcid.org/0009-0006-5351-4234","https://orcid.org/0000-0003-0958-5597"]},"institutions":[{"id":"https://openalex.org/I4210100616","display_name":"Institute of Oncology Prof. Dr. Ion Chiricuta","ror":"https://ror.org/00nrbsf87","country_code":"RO","type":"facility","lineage":["https://openalex.org/I4210100616"]}],"countries":["RO"],"is_corresponding":false,"raw_author_name":"Tudor E. Ciuleanu","raw_affiliation_strings":["Institut Oncologic, Cluj-Napoca, Romania"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institut Oncologic, Cluj-Napoca, Romania","institution_ids":["https://openalex.org/I4210100616"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078629724","display_name":"Mark A. Socinski","orcid":"https://orcid.org/0000-0003-2915-9325","observed_orcids":["https://orcid.org/0000-0003-2915-9325","https://orcid.org/0000-0002-8213-0137"]},"institutions":[{"id":"https://openalex.org/I170201317","display_name":"University of Pittsburgh","ror":"https://ror.org/01an3r305","country_code":"US","type":"education","lineage":["https://openalex.org/I170201317"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mark A. Socinski","raw_affiliation_strings":["University of Pittsburgh, Pittsburgh, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Pittsburgh, Pittsburgh, PA","institution_ids":["https://openalex.org/I170201317"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016064449","display_name":"Coleman K. Obasaju","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Coleman K. Obasaju","raw_affiliation_strings":["Eli Lilly and Company, Indianapolis, IN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eli Lilly and Company, Indianapolis, IN","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067943928","display_name":"Alexander Valerievich Luft","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Alexander Luft","raw_affiliation_strings":["Leningrad Regional Clinical Hospital, St. Petersburg, Russia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Leningrad Regional Clinical Hospital, St. Petersburg, Russia","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113629540","display_name":"Aleksandra Szcz\u0119sna","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Aleksandra Szczesna","raw_affiliation_strings":["Mazovian Centre of Pulmonary Diseases and Tuberculosis, Otwock, Poland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mazovian Centre of Pulmonary Diseases and Tuberculosis, Otwock, Poland","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062318634","display_name":"W Szafra\u0144ski","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Wojciech Szafranski","raw_affiliation_strings":["Voivodeship Specialist Hospital, Radom, Poland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Voivodeship Specialist Hospital, Radom, Poland","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015309335","display_name":"Rodryg Ramlau","orcid":"https://orcid.org/0000-0002-3199-2298","observed_orcids":["https://orcid.org/0000-0002-3199-2298"]},"institutions":[{"id":"https://openalex.org/I120230055","display_name":"Poznan University of Medical Sciences","ror":"https://ror.org/02zbb2597","country_code":"PL","type":"education","lineage":["https://openalex.org/I120230055"]}],"countries":["PL"],"is_corresponding":false,"raw_author_name":"Rodryg Ramlau","raw_affiliation_strings":["Med. Polonia Hospital, Pozna\u00f1, Poland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Med. Polonia Hospital, Pozna\u00f1, Poland","institution_ids":["https://openalex.org/I120230055"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111977754","display_name":"Beatrix B\u00e1lint","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Beatrix B\u00e1lint","raw_affiliation_strings":["Csongr\u00e1d County Hospital of Chest Diseases, Deszk, Hungary"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Csongr\u00e1d County Hospital of Chest Diseases, Deszk, Hungary","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108518026","display_name":"Andrzej Ka\u017carnowicz","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Andrzej Kazarnowicz","raw_affiliation_strings":["Tuberculosis and Lung Disease Hospital, Olsztyn, Poland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Tuberculosis and Lung Disease Hospital, Olsztyn, Poland","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077305357","display_name":"Olivier Molinier","orcid":"https://orcid.org/0000-0002-7965-2989","observed_orcids":["https://orcid.org/0000-0002-7965-2989"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Olivier Molinier","raw_affiliation_strings":["CH of Le Mans, Le Mans, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CH of Le Mans, Le Mans, France","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108572555","display_name":"Henrik Depenbrock","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210110958","display_name":"Eli Lilly (Germany)","ror":"https://ror.org/01pmvz131","country_code":"DE","type":"company","lineage":["https://openalex.org/I168537998","https://openalex.org/I4210110958"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Henrik Depenbrock","raw_affiliation_strings":["Lilly Deutschland GmbH, Bad Homburg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lilly Deutschland GmbH, Bad Homburg, Germany","institution_ids":["https://openalex.org/I4210110958"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035136964","display_name":"Shivani Nanda","orcid":"https://orcid.org/0000-0001-6358-2392","observed_orcids":["https://orcid.org/0000-0001-6358-2392"]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Shivani Nanda","raw_affiliation_strings":["Eli Lilly and Company, Bridgewater, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eli Lilly and Company, Bridgewater, NJ","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052765751","display_name":"Luis G Paz-Ares","orcid":"https://orcid.org/0000-0002-1947-3364","observed_orcids":["https://orcid.org/0000-0002-1947-3364"]},"institutions":[{"id":"https://openalex.org/I4210101691","display_name":"Hospital Universitario 12 De Octubre","ror":"https://ror.org/00qyh5r35","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210101691","https://openalex.org/I4210139293"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Luis Paz-Ares","raw_affiliation_strings":["Hospital Universitario 12 de Octubre, Madrid, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital Universitario 12 de Octubre, Madrid, Spain","institution_ids":["https://openalex.org/I4210101691"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5110052001","display_name":"N. Thatcher","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210131968","display_name":"The Christie Hospital","ror":"https://ror.org/03nd63441","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210131968","https://openalex.org/I4210133995"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Nick Thatcher","raw_affiliation_strings":["The Christie Hospital, Manchester, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Christie Hospital, Manchester, United Kingdom","institution_ids":["https://openalex.org/I4210131968"]}]}],"institutions":[],"countries_distinct_count":6,"institutions_distinct_count":7,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"33","issue":"15_suppl","first_page":"e19024","last_page":"e19024"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.9721999764442444,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.9721999764442444,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10202","display_name":"Lung Cancer Diagnosis and Treatment","score":0.01730000041425228,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12334","display_name":"Lung Cancer Research Studies","score":0.002899999963119626,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/necitumumab","display_name":"necitumumab","score":0.9990000128746033},{"id":"https://openalex.org/keywords/squamous-cell-non-small-cell-lung-cancer","display_name":"squamous cell non-small cell lung cancer","score":0.8809999823570251},{"id":"https://openalex.org/keywords/stage-iv-nsclc","display_name":"stage IV NSCLC","score":0.8320000171661377},{"id":"https://openalex.org/keywords/gemcitabine-cisplatin","display_name":"gemcitabine plus cisplatin","score":0.8939999938011169},{"id":"https://openalex.org/keywords/continuation-therapy","display_name":"continuation treatment","score":0.9330000281333923},{"id":"https://openalex.org/keywords/egfr-inhibition","display_name":"EGFR inhibition","score":0.5289999842643738},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.8389999866485596},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":1.0},{"id":"https://openalex.org/keywords/treatment-safety","display_name":"treatment safety","score":0.699999988079071},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.7559999823570251},{"id":"https://openalex.org/keywords/subgroup-analysis","display_name":"subgroup analysis","score":0.6489999890327454},{"id":"https://openalex.org/keywords/maintenance-therapy","display_name":"maintenance therapy","score":0.3499999940395355},{"id":"https://openalex.org/keywords/egfr-tyrosine-kinase-inhibitors","display_name":"EGFR tyrosine kinase inhibitors","score":0.5559999942779541},{"id":"https://openalex.org/keywords/egfr-mutation-status","display_name":"EGFR mutation status","score":0.4309999942779541},{"id":"https://openalex.org/keywords/egfr-expression","display_name":"EGFR expression","score":0.4050000011920929}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8540492653846741},{"id":"https://openalex.org/C187960798","wikidata":"https://www.wikidata.org/wiki/Q7631152","display_name":"Subgroup analysis","level":3,"score":0.5269960761070251},{"id":"https://openalex.org/C2780907072","wikidata":"https://www.wikidata.org/wiki/Q579516","display_name":"Squire","level":2,"score":0.495903342962265},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.46000009775161743},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4487239718437195},{"id":"https://openalex.org/C95190672","wikidata":"https://www.wikidata.org/wiki/Q815382","display_name":"Meta-analysis","level":2,"score":0.19174474477767944},{"id":"https://openalex.org/C41895202","wikidata":"https://www.wikidata.org/wiki/Q8162","display_name":"Linguistics","level":1,"score":0.0994405746459961},{"id":"https://openalex.org/C138885662","wikidata":"https://www.wikidata.org/wiki/Q5891","display_name":"Philosophy","level":0,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2015.33.15_suppl.e19024","doi":"https://doi.org/10.1200/jco.2015.33.15_suppl.e19024","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2015.33.15_suppl.e19024","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9940000176429749}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2568915723","https://openalex.org/W1991102850","https://openalex.org/W2762067471","https://openalex.org/W2936631831","https://openalex.org/W2342934429","https://openalex.org/W2587237959","https://openalex.org/W2601554568","https://openalex.org/W2252448228","https://openalex.org/W2891075531","https://openalex.org/W2495836927"],"abstract_inverted_index":{"e19024":[0],"Background:":[1],"The":[2],"SQUIRE":[3],"study":[4],"demonstrated":[5],"that":[6],"the":[7,49,54,133,143,160,307],"addition":[8],"of":[9,44,53,145,162,177,190,206,302,318,326,353,358,363],"necitumumab":[10],"(N)":[11],"to":[12,48,62,100,246],"gemcitabine-cisplatin":[13],"(GC)":[14],"improved":[15],"survival":[16,122,125],"in":[17,104,132,150,168,193,198,228,250,257,281,306,324,335,339],"patients":[18,33],"(pts)":[19],"with":[20,106,329],"stage":[21],"IV":[22],"sq-NSCLC.":[23],"This":[24,164],"retrospective":[25],"analysis":[26,165],"compares":[27],"safety":[28,128],"and":[29,71,87,127,139,148,156,185,208,219,313],"efficacy":[30],"outcomes":[31],"for":[32,130],"who":[34,136,153,171],"received":[35,172,186],"N":[36,81,111,146,191,330],"single":[37],"agent":[38],"as":[39],"continuation":[40,50],"therapy":[41],"after":[42,316],"completion":[43,161,317],"chemotherapy":[45],"treatment":[46,322],"(CT)":[47],"therapy-eligible":[51],"population":[52],"GC":[55,63,92,151,199,220,261,284],"arm.":[56,195],"Methods:":[57],"Pts":[58,103,311,354,359,364],"were":[59,137,154,182,209,214],"randomized":[60],"1:1":[61],"(G":[64],"=":[65,74,275,298,351,356,361],"1250":[66],"mg/m\u00b2":[67,76],"iv,":[68,77,84],"days":[69,85,98],"1":[70,86,188],"8;":[72],"C":[73],"75":[75],"day":[78],"1)":[79],"plus":[80],"(800":[82],"mg":[83],"8)":[88],"(GC+N":[89],"arm),":[90],"or":[91,116],"alone":[93,112,147,192,331],"(GC":[94],"arm)":[95],"every":[96],"21":[97],"up":[99],"6":[101],"cycles.":[102],"GC+N":[105,134,194,218,258,282],"no":[107],"progression":[108,140,157,183,210,314],"continued":[109],"on":[110],"until":[113],"progressive":[114],"disease":[115],"intolerable":[117],"toxicity.":[118],"We":[119],"present":[120],"overall":[121],"(OS),":[123],"progression-free":[124],"(PFS),":[126],"(TEAEs)":[129],"pts":[131,149,167,181,197,285],"arm":[135,152,200,259,262],"alive":[138,155,312],"free":[141,158,184,315],"at":[142,159,173,202],"start":[144],"CT.":[163,178],"included":[166],"both":[169,229,251],"arms":[170],"least":[174,203],"4":[175,204],"cycles":[176,205],"Results:":[179],"261":[180],"\u2265":[187,369,374,378],"dose":[189],"215":[196],"completed":[201],"CT":[207,247,319,346],"free.":[211],"Baseline":[212],"characteristics":[213],"well":[215],"balanced":[216,249],"between":[217],"arms,":[221],"respectively:":[222],"median":[223],"age":[224],"was":[225,248],"62":[226],"yrs":[227],"arms;":[230],"males":[231],"81%":[232],"vs":[233,237,243,260,265,283,288],"89%;":[234],"whites":[235],"82%":[236],"85%;":[238],"ECOG":[239],"PS":[240],"0-1":[241],"94%":[242],"95%.":[244],"Exposure":[245],"arms.":[252],"Median":[253,277],"OS":[254],"from":[255,279],"randomization":[256,280],"were:":[263,286],"15.9":[264],"15":[266],"months":[267,290],"(HR":[268,291],"0.85":[269],"[95%":[270,293],"CI,":[271,294],"0.69,":[272],"1.05];":[273],"p":[274,297],"0.139).":[276],"PFS":[278],"7.4":[287],"6.9":[289],"0.86":[292],"0.70,":[295],"1.06],":[296],"0.150).":[299],"Select":[300],"TEAEs":[301],"relevance":[303],"are":[304],"shown":[305],"table":[308],"below.":[309],"Conclusions:":[310],"had":[320],"consistent":[321],"effect":[323],"favor":[325],"GC+N.":[327],"Continuation":[328,348],"did":[332],"not":[333],"result":[334],"any":[336],"unexpected":[337],"increases":[338],"adverse":[340],"events.":[341],"Clinical":[342],"trial":[343],"information:":[344],"NCT00981058.":[345],"Phase":[347,349],"GC+NN":[350],"261%":[352,362],"GCN":[355],"215%":[357],"NN":[360],"Category":[365],"Any":[366,371],"Grade":[367,368,372,373,377],"3":[370,375,379],"AnyGrade":[376],"Neutropenia":[380],"54.4":[381],"33.3":[382],"55.8":[383],"32.1":[384],"0.4":[385,386],"Hypomagnesemia":[387],"40.2":[388],"14.2":[389],"18.6":[390],"0.9":[391,416],"16.1":[392],"2.7":[393,417],"Rash":[394],"85.8":[395],"5.7":[396],"10.2":[397],"0.5":[398,406],"26.1":[399],"4.2":[400,415],"Arterial":[401],"thromboembolic":[402,411],"event":[403,412],"3.4":[404],"1.1":[405],"0":[407],"2.3":[408,414],"1.9":[409,418],"Venous":[410],"7.3":[413]},"counts_by_year":[{"year":2017,"cited_by_count":1}],"updated_date":"2026-10-14T16:39:01.820549","created_date":"2017-04-07T00:00:00"}